"Ck Life Sciences is to diversify from the development and sale of agricultural-based nutritional and pharmaceutical products into the business of owning vinewards." from South China Morning Post

"The Hong Kong-listed bio-technology company announced yesterday it had agreed to buy a majority stake in Australian-listed Challenger Wine Trust for HK$260 million."